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Background: Standard measurements of LDL strongly predict coronary artery disease (CAD) in randomized trials. However, a large percentage 
of CAD patients have achieved “target” LDL levels in clinical practice but remain at high residual risk. To address this, LDL subfractions have been 
proposed as a means of improving risk assessment, but their incremental predictive ability for CAD has been inadequately studied. 
Methods: Participants (N=2,429) of the Intermountain Heart Collaborative Study were evaluated. LDL1 (most buoyant)-LDL4 (most dense) 
subfractions were determined using the Vertical Auto Profile method. The percent of buoyant LDL [100*(LDL1+LDL2)/LDL] and dense LDL 
[100*(LDL3+LDL4)/LDL] was divided into tertiles (T). Logistic regression was utilized to determine associations of LDL subfractions with CAD.
Results: Patients averaged 62.6±12.6 years and 65.4% were male. Abnormal LDL levels (>100 mg/dL) were found among 48.1% (n=1168) of the 
population. Among those with normal LDL levels, the percent of buoyant LDL (T2 v. T1: OR=1.10, p=0.65; T3 v. T1: OR=0.64, p=0.03) and dense LDL 
(T2 v. T1: OR=1.68, p=0.01; T3 v. T1: OR=1.54, p=0.04) were associated with CAD in univariable analysis, but these associations were attenuated 
after adjustment (buoyant LDL: T2 v. T1: OR=1.35, p=0.22; T3 v. T1: OR=1.01, p=0.98; dense LDL: T2 v. T1: OR=1.17, p=0.52; T3 v. T1: OR=1.15, 
p=0.55). For those with abnormal LDL levels, the percent of buoyant and dense LDL were not associated with CAD. When comparing LDL phenotypes, 
phenotypes A/B and B were associated with CAD among those with normal LDL (A/B vs. A: OR=1.61, p=0.01; B v. A: OR=1.81, p=0.001), though 
these associations were attenuated after adjustment (A/B v. A: OR=1.52, p=0.05; B v. A: OR=1.36, p=0.16). LDL phenotypes were not predictive 
among those with abnormal LDL levels.
Conclusion: Although LDL targets in CAD patients are often achieved in clinical practice, substantial risk remains. We demonstrate here that 
LDL subfractions may predict CAD risk, particularly among those with normal LDL levels. Although significance was not always achieved, these 
subfractions represent a potential treatment target and should be tested in a larger cohort.
